Venus Remedies Ltd Annually Results

337.85
(-0.57%)
Dec 10, 2024|03:31:10 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

601.45

555.51

600.18

548.12

341.46

Excise Duty

0

0

0

0

0

Net Sales

601.45

555.51

600.18

548.12

341.46

Other Operating Income

0

0

0

0

0

Other Income

11.58

10.32

8.31

43.07

5.31

Total Income

613.03

565.83

608.49

591.2

346.77

Total Expenditure

541.85

495.49

538.07

494.35

309.49

PBIDT

71.18

70.34

70.42

96.85

37.29

Interest

0.09

0.12

0.48

13.02

13.31

PBDT

71.09

70.22

69.94

83.83

23.98

Depreciation

26.44

32.3

33.53

35.28

32.01

Minority Interest Before NP

0

0

0

0

0

Tax

12.22

0

0

-13.21

1.96

Deferred Tax

3.94

11.36

-4.32

0

0

Reported Profit After Tax

28.49

26.56

40.73

61.77

-10

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

28.49

26.56

40.73

61.77

-10

Extra-ordinary Items

0

0

0

23.44

-6.85

Adjusted Profit After Extra-ordinary item

28.49

26.56

40.73

38.33

-3.15

EPS (Unit Curr.)

21.31

19.88

30.86

50.04

-8.1

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

13.37

13.37

13.37

12.34

12.34

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

11.83

12.66

11.73

17.66

10.92

PBDTM(%)

11.81

12.64

11.65

15.29

7.02

PATM(%)

4.73

4.78

6.78

11.26

-2.92

Venus Remedies: Related NEWS

Venus Remedies gets approval for pre-filled syringe facility
6 Nov 2024|10:36 AM

Furthermore, the NPRA's recognition will enable Venus Remedies to capitalise on the expanding global demand for enoxaparin.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp